Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 29, 2024
Reporting Period: Quarter ended June 30, 2024
This filing announces the issuance of a press release containing preliminary and unaudited financial results for the second quarter of 2024. The full details of the results are contained in Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the press release (Exhibit 99.1) but are not present in the body of this Form 8-K summary.
Material Changes
No specific material changes or comparative data versus prior periods are detailed in this filing text. The document serves solely to notify the market of the release of preliminary results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the results are preliminary and unaudited.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended June 30, 2024.
- Verify the unaudited nature of the reported results before making investment decisions.
- Check for any forward-looking statements or updated guidance within the full press release text.
- Confirm the company's status as an emerging growth company (indicated as checked in the filing).